Agency Forms Undergoing Paperwork Reduction Act Review, 77159-77160 [2024-21571]
Download as PDF
<![CDATA[
77159
Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices
individuals throughout the United
States.
This revision seeks approval to
conduct changes to all three
components of NAMCS. CDC plans to
adjust the HC Component and Provider
Survey Component sample sizes. In
2025 the goal is to sample 10,000
advanced practice providers and up to
151 HCs. In 2026 we plan to sample up
to 10,000 physicians and up to 171 HCs
if funds allow. If funds allow, in 2027
we will sample up to 10,000 advanced
practice providers and up to 191 HCs.
For 2025–2027, there will be an
additional 3,000 providers sampled
yearly for the Provider Electronic
Component. Questions on the Provider
Facility Interview, Health Center
Facility Interview, and the Ambulatory
Care Provider Interview will also be
modified.
CDC requests OMB approval for an
estimated 22,107 annual burden hours.
There is no cost to respondents other
than their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
HC’s Staff .................................................
HC Facility Interview Questionnaire (Survey year: 2024).
Prepare and transmit EHR for Visit Data
(quarterly) (Survey year: 2024).
Set-up Fee Questionnaire (Survey year:
2024).
ACPI (Survey year: 2026) .......................
Contact Tracing (Survey year: 2026) ......
ACPI (Survey year: 2025 & 2027) ..........
Contact Tracing (Survey year: 2025 &
2027).
PFI (Survey year: 2025–2027) ................
Prepare and transmit Electronic Visit
Data (quarterly) (Survey year: 2025–
2027).
HC Facility Interview Questionnaire (Survey year: 2025–2027).
Prepare and transmit EHR for Visit Data
(quarterly) (Survey year: 2025–2027).
Set-up Fee Questionnaire (Survey year:
2025–2027).
Provider or Staff .......................................
Advanced Practice Provider or Staff .......
Ambulatory Care Provider’s or Group’s
or Conglomerate’s Staff.
HC’s Staff .................................................
Total ..................................................
..................................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–21573 Filed 9–19–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–24AH]
ddrumheller on DSK120RN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Institutional
Review Board Authorization Agreement
for Human Research’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
VerDate Sep<11>2014
16:44 Sep 19, 2024
Jkt 262001
Number of
responses per
respondent
84
1
45/60
63
50
4
60/60
200
17
1
15/60
4
3,333
3,333
6,667
6,667
1
1
1
1
30/60
10/60
30/60
10/60
1,667
556
3,334
1,111
3,000
3,000
1
4
45/60
60/60
2,250
12,000
221
1
45/60
166
188
4
60/60
752
17
1
15/60
4
....................
........................
....................
22,107
Recommendations’’ notice on October
30, 2023, to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
Avg.
burden per
response
(in hrs.)
Number of
respondents
Total
burden
(in hrs.)
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
E:\FR\FM\20SEN1.SGM
20SEN1
77160
Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices
Proposed Project
Institutional Review Board
Authorization Agreement for Human
Research—New—Office of Science (OS),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The CDC Human Research Protection
Office (HRPO) often receives requests
from outside institutions seeking to rely
on the CDC Institutional Review Board
(IRB) for review of a research study.
This arrangement also allows multiple
institutions to use, or rely on, the CDC
IRB for centralized review and approval
of research studies instead of review by
the site-specific IRBs, which helps
reduce duplication of effort, delays, and
expenses. To meet regulatory
requirements, institutions that elect to
rely on the CDC IRB are required to
complete a CDC IRB Authorization
Agreement for Human Research and a
Local Context Survey. The goal is to use
the agreement and survey to provide
regulatory oversight for human subjects
research, to maintain records, and to
track those institutions that have elected
to rely on the CDC IRB for review.
CDC requests OMB approval for an
estimated 450 annual burden hours.
There is no cost to respondents other
than their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Hospital/Academic Institutions/IRB
Administrators.
Hospital/Academic Institutions/IRB
Administrators.
CDC IRB Authorization Agreement for Human Research (for review, completion, and submission to
CDC).
Local context survey (for completion and submission
to CDC).
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–21571 Filed 9–19–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–1365; Docket No. CDC–2024–
0069]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Program Evaluation of CDC’s Core
State Injury Prevention Program. This
project allows CDC to collect
information from awardees funded
under the Core State Injury Prevention
Program.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:43 Sep 19, 2024
Number
of respondents
Form name
Jkt 262001
CDC must receive written
comments on or before November 19,
2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0069 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
DATES:
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
Number
responses per
respondent
Avg. burden
per response
(in hrs.)
150
1
1
150
1
2
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Program Evaluation of CDC’s Core
State Injury Prevention Program (OMB
Control No. 0920–1365, Exp. 7/31/
2025)—Revision—National Center for
Injury Prevention and Control (NCIPC),
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 89, Number 183 (Friday, September 20, 2024)]
[Notices]
[Pages 77159-77160]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21571]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-24AH]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Institutional Review Board Authorization
Agreement for Human Research'' to the Office of Management and Budget
(OMB) for review and approval. CDC previously published a ``Proposed
Data Collection Submitted for Public Comment and Recommendations''
notice on October 30, 2023, to obtain comments from the public and
affected agencies. CDC received one comment related to the previous
notice. This notice serves to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
[[Page 77160]]
Proposed Project
Institutional Review Board Authorization Agreement for Human
Research--New--Office of Science (OS), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The CDC Human Research Protection Office (HRPO) often receives
requests from outside institutions seeking to rely on the CDC
Institutional Review Board (IRB) for review of a research study. This
arrangement also allows multiple institutions to use, or rely on, the
CDC IRB for centralized review and approval of research studies instead
of review by the site-specific IRBs, which helps reduce duplication of
effort, delays, and expenses. To meet regulatory requirements,
institutions that elect to rely on the CDC IRB are required to complete
a CDC IRB Authorization Agreement for Human Research and a Local
Context Survey. The goal is to use the agreement and survey to provide
regulatory oversight for human subjects research, to maintain records,
and to track those institutions that have elected to rely on the CDC
IRB for review.
CDC requests OMB approval for an estimated 450 annual burden hours.
There is no cost to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number Avg. burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
Hospital/Academic Institutions/IRB CDC IRB Authorization 150 1 1
Administrators. Agreement for Human
Research (for review,
completion, and
submission to CDC).
Hospital/Academic Institutions/IRB Local context survey 150 1 2
Administrators. (for completion and
submission to CDC).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-21571 Filed 9-19-24; 8:45 am]
BILLING CODE 4163-18-P
